Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared with One Human Leukocyte Antigen Mismatched Related Donors Using HLA Typing at 10 Loci

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 6, 2011, Pages 923-929

  Ciurea, Stefan O ^a   Saliba, Rima M ^a   Rondon, Gabriela ^a   Patah, Poliana A ^b   Aung, Fleur ^a   Cano, Pedro ^a   Andersson, Borje S ^a   Kebriaei, Partow ^a   Popat, Uday ^a   Fernandez Vina, Marcelo ^a   Champlin, Richard E ^a   De Lima, Marcos ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

9 10 matched related donors; Class I HLA mismatch; Class II HLA mismatch; Hematopoietic stem cell transplantation; HLA matched unrelated donors

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DR1 ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD DONOR; CHILD; GRAFT REJECTION; HLA MATCHING; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MYELOID LEUKEMIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL;

ALLELES; BLOOD DONORS; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 79955992249     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.10.017     Document Type: Article

References (27)

1. Copelan E. Hematopoietic stem-cell transplantation. N Engl J Med 2006, 354:1813-1826.
2. Sasazuki T., Juji T., Morishima Y., et al. Effect of matching of class I HLA alleles on outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Eng J Med 1998, 339:1177-1185.
3. Kiehl M.G., Kraut L., Schwerdtfeger R., et al. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. J Clin Oncol 2004, 22:2816-2825.
4. Yakoub-Agha I., Mesnil F., Kuentz M., et al. Allogeneic marrow stem cell transplantation from human leukocyte antigen-identical sibling versus human leukocyte antigen-allelic-matched unrelated (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol 2006, 24:5695-5702.
5. Moore J., Nivison-Smith I., Goh K., et al. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia. Biol Blood Marrow Transplant 2007, 13:601-607.
6. Schetelig J., Bornhäuser M., Schmid C., et al. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group. J Clin Oncol 2008, 26:5183-5191.
7. Petersdorf E.W., Hansen J.A., Martin P.J., et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med 2001, 345:1794-1800.
8. Weisdorf D.J., Anasetti C., Antin J.H., et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. Blood 2002, 99:1971-1977.
9. Arora M., Weisdorf D.J., Spellman S.R., et al. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. J Clin Oncol 2009, 27:1644-1652.
10. Lee S.J., Klein J., Haagenson M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
11. Weisdorf D., Spellman S., Haagenson M., et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 2008, 14:748-758.
12. Szydlo R., Goldman J.M., Klein J.P., et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997, 15:1767-1777.
13. Hasegawa W., Lipton J.H., Messner H.A., et al. Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors. Hematology 2003, 8:27-33.
14. Kanda Y., Chiba S., Hirai H., et al. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000). Blood 2003, 102:1541-1547.
15. Ottinger H.D., Ferencik S., Beelen D.W., et al. Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA mismatched related donors, and HLA-matched unrelated donors. Blood 2003, 102:1131-1137.
16. Parmar S., de Lima M., Zou T., et al. Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease. Blood 2009, 114:2884-2887.
17. Kaplan E.L., Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
18. Prentice R.L., Kalbfleisch J.D., Peterson A.V., et al. The analysis of failure times in the presence of competing risks. Biometrics 1978, 34:541-554.
19. Cox R.D. Regression analysis and life tables. J R Stat Soc 1972, 34:187-220.
20. Ottinger H., Grosse-Wilde M., Schmitz A., Grosse-Wilde H. Immunogenetic marrow donor search for 1012 patients: a retrospective analysis of strategies, outcome and costs. Bone Marrow Transplant 1994, 14:S34-38.
21. Goulmy E., Schipper R., Pool J., et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996, 334:281-285.
22. Anasetti C., Amos D., Beatty P.G., et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989, 320:197-204.
23. Leung W.H., Turner V., Richardson S.L., et al. Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors. Hum Immunol 2001, 62:399-407.
24. Morishima Y., Sasazuki T., Inoko H., et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B and HLA-DR matched unrelated donors. Blood 2002, 99:4200-4206.
25. Flomenberg N., Baxter-Lowe L.A., Confer D., et al. Impact of HLA class I and class II high resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004, 104:1923-1930.
26. Ciurea S.O., de Lima M., Cano P., et al. High risk of graft failure with anti-HLA antibodies undergoing haploidentical stem-cell transplantation. Transplantation 2009, 88:1019-1024.
27. Ciurea S.O., de Lima M., Kebriaei P., et al. Safety of T-cell replete haploidentical stem cell transplantation using fludarabine, melphalan and thiotepa conditioning and high-dose post transplant cyclophosphamide. Biol Blood Marrow Transplant 2010, 16:s218. (abstract #163).